Disposition of 11000 shares by Gwendolyn Binder of Cabaletta Bio at 1.01 subject to Rule 16b-3
CABA Stock | USD 4.91 0.06 1.24% |
About 62% of all Cabaletta Bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Cabaletta Bio suggests that some traders are interested. The current market sentiment, together with Cabaletta Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Cabaletta Bio stock news signals to limit their universe of possible portfolio assets.
Cabaletta |
Filed transaction by Cabaletta Bio Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Cabaletta Bio's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cabaletta Bio's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Cabaletta Bio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cabaletta Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cabaletta Bio Fundamental Analysis
We analyze Cabaletta Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cabaletta Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cabaletta Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Cabaletta Bio is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Cabaletta Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cabaletta Bio stock to make a market-neutral strategy. Peer analysis of Cabaletta Bio could also be used in its relative valuation, which is a method of valuing Cabaletta Bio by comparing valuation metrics with similar companies.
Peers
Cabaletta Bio Related Equities
PLRX | Pliant Therapeutics | 3.61 | ||||
BDTX | Black Diamond | 2.80 | ||||
MDGL | Madrigal Pharmaceuticals | 1.89 | ||||
ETNB | 89bio | 1.71 | ||||
ACLX | Arcellx | 1.67 | ||||
RVMD | Revolution Medicines | 0.86 | ||||
DAWN | Day One | 0.46 | ||||
LRMR | Larimar Therapeutics | 1.15 | ||||
STOK | Stoke Therapeutics | 2.03 | ||||
ALEC | Alector | 3.11 | ||||
PASG | Passage Bio | 3.33 |
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Transaction History View history of all your transactions and understand their impact on performance |